Early sST2 Liberation after Implantation of a Left Ventricular Assist Device in Patients with Advanced Heart Failure

Table 1

Baseline characteristics of the study population ().

Variables
	1-year survivors ()	1-year nonsurvivors ()	value
Age (y)	59 (56-69)	64 (60-69)	0.21^a
BMI (kg/m^2)	24.7 (22.7-29)	24.9 (22.8-34.4)	0.55^a
Female	4 (30.8)	2 (28.6)	0.92^b
Ntpro-BNP (pg/ml)	6094 (3856-6818)	5492 (1918-15000)	0.84^a
INTERMACS level			0.83^b
I	1 (7.6)	1 (14.3)
II	3 (23)	1 (14.3)
III	7 (53.8)	3 (42.9)
IV	2 (15.3)	2 (28.6)
Therapeutic intent
Bridge to decision	0 (0)	1 (14.3)
Bridge to candidacy	8 (61.5)	4 (57.1)
Bridge to transplant	1 (7.7)	0 (0)
Destination therapy	4 (30.8)	2 (28.6)
Diabetes			0.37^b
NIDDM	0 (0)	1 (14.3)
IDDM	4 (30.8)	2 (28.6)
History of arterial hypertension	9 (69.2)	4 (57.1)	0.58^b
CHA2DS2-VASc score	3 (3-4)	3 (2-5)	1^a
Malignant arrhythmia	2 (15.3)	1 (14.3)	0.94^b
COLD	6 (46.2)	1 (14.3)	0.32^b
Renal insufficiency (including patients on HF)	9 (69.2)	3 (42.9)	0.35^b
Creatinine (mg/dl)	1.25 (0.91-1.4)	1.04 (1.01-1.8)	0.6^a
Left ventricular ejection fraction (%)	20 (15-25)	20 (15-25)	0.93^a
Systolic PAP (mmHg)	59 (45-67)	47 (38-57)	0.21^a
Types of cardiomyopathy (CMP)			0.58^b
Ischemic CMP	9 (69.2)	4 (57.1)
Dilated CMP	4 (30.8)	3 (42.9)

Values are medians with interquartile ranges (IQRs) or absolute numbers (percentages); ^aMann–Whitney test, ^bFisher exact or chi-square test. BMI = body mass index; BNP = brain natriuretic peptide; INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support; NIDDM = non-insulin-dependent diabetes mellitus; CHA2DS2-VASc score = congestive heart failure, hypertension, , diabetes, prior, stroke/transient ischemic attack; IDDM = insulin-dependent diabetes mellitus; COLD = chronic obstructive lung disease; HF = hemofiltration; PAP = pulmonary artery pressure.